Drug Information

Drug General Information
Drug ID
D0U3SY
Drug Name
Alectinib
Drug Type
Small molecular drug
Indication Lung Cancer [ICD10:C33-C34] Approved [1572608]
Discovery agent Investigative [1572605]
Formula
C30H34N4O2
PubChem Compound ID
49806720
Drug Resistance Mutation (DRM)
DRM DRM Info
References
Ref 1572605The ChEMBL database in 2017.
Ref 1572608Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.